Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 13 Jul 2026 17:08 CEST |
ZELLUNA | Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Jul 2026 17:08 CEST |
ZELLUNA | Zelluna doserer første pasient med ZI-MA4-1 i fase 1-studien ZIMA-101 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 02 Jul 2026 14:33 CEST |
ZELLUNA | Zelluna ASA - Grant of Share Options | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 30 Jun 2026 10:12 CEST |
ZELLUNA | Zelluna ASA awarded NOK 16 million Research Council of Norway grant | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Jun 2026 10:12 CEST |
ZELLUNA | Zelluna ASA tildelt NOK 16 millioner i tilskudd fra Forskningsrådet | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 29 Jun 2026 13:03 CEST |
ZELLUNA | Zelluna ASA: Mandatory notification of trade - Return of lent shares following Private Placement | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 29 Jun 2026 09:59 CEST |
ZELLUNA | Zelluna ASA: New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Jun 2026 08:30 CEST |
ZELLUNA | Zelluna ASA aktiverer The Royal Marsden som det andre kliniske senteret for ZIMA-101, og utvider kapasiteten for klinisk gjennomføring | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 29 Jun 2026 08:30 CEST |
ZELLUNA | Zelluna ASA activates The Royal Marsden as second clinical site for ZIMA-101, expanding clinical execution capabilities | 20103010 Biotechnology | Non-regulatory press releases |
| 26 Jun 2026 16:40 CEST |
ZELLUNA | Readout from Legacy Ultimovacs DOVACC Phase II Trial Concludes UV1 Programme as Previously Guided | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Jun 2026 16:40 CEST |
ZELLUNA | Resultater fra Ultimovacs' DOVACC fase II-studie bekrefter avslutningen av UV1-programmet, i tråd med tidligere kommunisert plan | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 18 Jun 2026 11:08 CEST |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 18 Jun 2026 00:28 CEST |
ZELLUNA | Zelluna ASA - Mandatory notification of trade - Subscription and share lending in Private Placement | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 18 Jun 2026 00:21 CEST |
ZELLUNA | Zelluna ASA: Private Placement and Retail Offering successfully placed | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Jun 2026 16:46 CEST |
ZELLUNA | Zelluna ASA: Contemplated Private Placement and Retail Offering to Strengthen its Position Ahead of Initial Clinical Data | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 May 2026 07:00 CEST |
ZELLUNA | Zelluna ASA: First Quarter 2026 results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 May 2026 07:00 CEST |
ZELLUNA | Zelluna ASA: Første kvartal 2026 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 06 May 2026 23:18 CEST |
ZELLUNA | Zelluna ASA aktiverer det første kliniske senteret for ZIMA-101studien, og markerer dermed oppstart av klinisk gjennomføring | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 06 May 2026 23:18 CEST |
ZELLUNA | Zelluna ASA activates first clinical site for ZIMA-101, marking entry into clinical execution | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 May 2026 17:58 CEST |
ZELLUNA | Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation (corrected time) | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 May 2026 15:19 CEST |
ZELLUNA | Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Apr 2026 09:37 CEST |
ZELLUNA | Zelluna ASA - Annual General Meeting held on April 23, 2026 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Apr 2026 11:25 CEST |
ZELLUNA | Zelluna ASA - Disclosure of voting rights of Annual General Meeting | 20103010 Biotechnology | Major shareholding notifications |
| 27 Mar 2026 10:01 CET |
ZELLUNA | Zelluna ASA - Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 26 Mar 2026 15:28 CET |
ZELLUNA | Zelluna to host Capital Markets Update 2026 | 20103010 Biotechnology | Non-regulatory press releases |
| 26 Mar 2026 08:57 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Mar 2026 07:00 CET |
ZELLUNA | Zelluna ASA [ZLNA]: Annual Report 2025 | 20103010 Biotechnology | Annual financial and audit Reports |
| 09 Mar 2026 08:00 CET |
ZELLUNA | Zelluna inngår samarbeid med Etcembly for AI-drevet TCR-utvikling | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 09 Mar 2026 08:00 CET |
ZELLUNA | Zelluna announces collaboration with Etcembly for AI-enabled TCR engineering | 20103010 Biotechnology | Non-regulatory press releases |
| 20 Feb 2026 14:30 CET |
ZELLUNA | Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Feb 2026 14:30 CET |
ZELLUNA | Zelluna mottar UK MHRA og etisk godkjenning for oppstart av ZIMA-101 første-i-menneske klinisk studie | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 12 Feb 2026 07:00 CET |
ZELLUNA | Zelluna ASA: Fjerde kvartal 2025 - Viktig regulatorisk milepæl oppnådd med CTA-innlevering | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 12 Feb 2026 07:00 CET |
ZELLUNA | Zelluna ASA: Fourth Quarter 2025 - Key regulatory milestone achieved with CTA Submission | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Feb 2026 08:00 CET |
ZELLUNA | Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Feb 2026 08:00 CET |
ZELLUNA | Zelluna inngår avtale med Medpace om første kliniske studie - pasientdata ventes fra medio 2026 | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 05 Feb 2026 13:30 CET |
ZELLUNA | Zelluna ASA - Grant of Share Options | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Feb 2026 09:30 CET |
ZELLUNA | Zelluna ASA: Invitation to Fourth Quarter 2025 Results Webcast Presentation | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Feb 2026 08:00 CET |
ZELLUNA | Zelluna promotes Emilie Gauthy to Chief Technology Officer | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Feb 2026 08:00 CET |
ZELLUNA | Zelluna utnevner Emilie Gauthy til Chief Technology Officer | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 15 Jan 2026 12:22 CET |
ZELLUNA | Zelluna ASA: Approval and publication of prospectus | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Dec 2025 17:26 CET |
ZELLUNA | Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World's First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Dec 2025 17:26 CET |
ZELLUNA | Zelluna har nådd en viktig milepæl og innleverer søknad om klinisk studie i Storbritannia for første studie på mennesker av ZI-MA4-1 (ZIMA-101), verdens første MAGE-A4-rettede TCR-NK celleterapi for solide kreftformer. | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 16 Dec 2025 12:36 CET |
ZELLUNA | Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World's First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Dec 2025 13:02 CET |
ZELLUNA | Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2025 09:36 CET |
ZELLUNA | Zelluna ASA: Cancellation of subsequent repair offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Dec 2025 08:22 CET |
ZELLUNA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Dec 2025 18:36 CET |
ZELLUNA | Zelluna ASA - Mandatory notification of trade | 20103010 Biotechnology | Major shareholding notifications |
| 08 Dec 2025 13:52 CET |
ZELLUNA | Zelluna ASA: New share capital registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2025 07:50 CET |
ZELLUNA | Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Nov 2025 08:35 CET |
ZELLUNA | Zelluna ASA: Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |